Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL INDUSTRY

The pharmaceutical industry operates under unique circumstances: Estimates of the cost to bring a single new drug to market range from $800 million to $1.2 billion, and on average, a patent’s life remaining upon FDA launch approval is only eight years. Thus, achieving the highest level of performance is critical to pharmaceutical companies. This topic is dedicated to marketing, market research, business operations, and management issues specific to the pharmaceutical industry.

Pharmaceutical Industry is part of Business Exchange, suggested by Ken Rhines. This topic contains 2,048 news and 765 blog items. Read updated news, blogs, and resources about Pharmaceutical Industry. Find user-submitted articles and reactions on Pharmaceutical Industry from like-minded professionals.

Most Active

The most active stories in this topic based on user activity.

Belvidere Pharmacy, Custom Medicine Makers, Moves to New, and Even Bet...more

HIGHLAND PARK, N.J., Feb. 1, 2012 (SEND2PRESS NEWSWIRE) -- 2012 marks an important milestone for Belvidere Pharmacy.

Overcoming Nasty Side-Effects Means the Difference Between Life and De...more

Profitability through Simplicity: Drug shortages: Cause and Curemore

International Conference on Critical Issues of 'Biosimilars' Hosted by...more

leading pharmaceutical lawyers, professors, regulators, payers, and industry officials speculated on how impending...

Profitability through Simplicity: Does the Pharmaceutical Industry Nee...more

Generics Fees: A Fantastic Opportunity | Pharmaceutical Processingmore

A Puzzling Amgen Move Into Biosimilarsmore

Amgen and Watson Pharmaceuticals struck a deal to develop and commercialize biosimilars, and while the arrangement...

The Pharmaceutical Industry Has Reached a Tipping Pointmore

Shaping the future of pharmaceutical R&D More News �� The research and development (R&D) process in the...

Patent Docs: If Patents Become Irrelevant in a Biosimilars Future, Wha...more

By Kevin E. Noonan -- The pros and cons of patenting in the biosimilars scheme recently enacted as part of the Patient...

Drugs for Infectious Diseases, Funding and Opportunity | Pharmaceutica...more

MonitorGroup: RT @epharma: The Ten Types of Innovation & the Evolu...more

MonitorGroup: RT @epharma: The Ten Types of Innovation & the Evolution of the New Pharma Models w/ Monitor Group @...

Printing A Human Kidneymore

Anthony Atala of Wake Forest University at TED talks about printing organs such as kidneys, with real cells and...

Pharmaceuticals for Freemore

As pharmaceutical companies begin to implement initiative such as patent pooling and providing cheap consumer drugs to...

Profitability through Simplicity: Pharmaceutical Quality: Is it a Comp...more

FDA Takes action against MADEmore

The Food and Drug Administration is taking actions against nutraceutical producer MADE (Manufacturing ATF Dedicated...

Pfizer to Sell Lipitor Directly to Patients After Patent Expiresmore

Pfizer is planning to sell Lipitor at generic prices directly to patients, part of an effort to hold onto sales of...

Trinity Insights | Getting the Most from a National Campaign at the Lo...more

By Brian Irwin Managing the pull-through of a successful national brand campaign at the local level is always...

Global Pharma Innovation at Abbottmore

Tom Mottola, Senior Business Systems Manager at Abbott, a global pharmaceuticals and health care products company,...

Profitability through Simplicity: Drug Prices: Food vs. Medicinemore

Biotech earnings // Patent loss // Biotech deals // Cancer drug develo...more

Reaction Biology Launches Recombinant Methyltransferase Line - Drugs a...more

MALVERN, Pa., Oct. 24, 2011 (SEND2PRESS NEWSWIRE) -- Reaction Biology Corporation ('RBC'), a leading contract research...

Reaction Biology Corporation Unveils Largest Kinase Profiling Data Set...more

MALVERN, Pa., Oct. 31, 2011 (SEND2PRESS NEWSWIRE) -- Reaction Biology Corporation ('RBC') today announced the...

Trinity Insights | Introducing Agile M - Mobile Sales Insights for Lif...more

By Zackary King Since its introduction last year, the iPad has quickly become the life sciences industry’s preferred...

Pharma: Chewing on growth pill has left a bad after-taste - CNBC-TV18more

Archana Shukla of CNBC-TV18 reports on why Ranbaxy, Glenmark and Lupin have not turned in a very strong performance...

Myth Busters Edition of The Plugged-In Managermore

Bill Choy, one of my past Executive MBA students often sends in challenging questions. Recently, it’s been examples of...

Topic Feed: Most active content in Pharmaceutical Industry

Top Sources: Pharmaceutical Industry

  • BusinessWeek
  • bloomberg.com
  • Reuters
  • pharmachemicalscoatings.blogspot.com
  • srcomblog.wordpress.com
  • New York Times
  • Industry Week
  • myharvardnews.com
  • Health Beat
  • pharmatching.com

Most Active Users in this Topic

see all contributors in Pharmaceutical Industry

Featured White Papers

Tweets on this Topic

Post a Job

Jobs in this Topic

Associate Director, Partnerships Marketing & Communications Michael J Fox Foundation | New York, NY
Posted: Feb 2
Pharmaceutical Sales Specialist - CVAS AstraZeneca | Spokane, WA
Posted: Jan 17
Account Director - Product Communications (pharmaceutical) Paradigm Staffing | Massachusetts
Posted: Jan 10
Analytical Chemist (Pharmaceutical QC) Lab Support, A Division of On Assignment | Lancaster, PA
Posted: Feb 2

Report comment contains invalid characters. ()
cancel
Search Cancel